Source: Annual Congress 2001 - Mechanisms of airway inflammation in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Antczak, P. Gorski (Lodz, Poland). Increased exhaled cysteinyl-leukotrienes, leukotriene B₄ and 8-isoprostane in exacerbation of COPD. Eur Respir J 2001; 16: Suppl. 31, 1696

Member's Comments

No comment yet.

Related content which might interest you: Cysteinyl leukotrienes and leukotriene B4 in expired breath condensate in patients with chronic asthma treated with montelukast Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003 Increased exhaled 8-isoprostane in aspirin-sensitive asthma Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001 Leukotriene B4 in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Corticosteroid reversibility testing and exhaled leukotriene B4 in patients with stable, severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Exacerbation of COPD-increased markers of oxidative stress and Leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 281s Year: 2002 Leukotriene B4 levels in sputum from asthma patients Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015 Year: 2016 Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Saliva is one likely source of leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2006; 28: 1229-1235 Year: 2006 Increased exhaled leukotrienes levels in adults with chronic cough Source: Eur Respir J 2003; 22: Suppl. 45, 475s Year: 2003 The effect of smoking on the levels of cysteinyl leukotriene in exhaled breath condensate in asthmatics Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Increased inflammatory markers in the exhaled breath condensate of cigarette smokers Source: Eur Respir J 2003; 21: 589-593 Year: 2003 Exhaled breath condensate: 8-isoprostane and eicosanoids Source: Eur Respir Monogr 2010; 49: 196-206 Year: 2010 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Urinary leukotriene E4 and exhaled nitric oxide on recovery from exercise-induced bronchospasm in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006 Urinary cysteinyl leukotriene levels in acute asthma Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 Leukotriene B4 in exhaled breath condensate of patients after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia Source: Eur Respir J 2008; 32: 437-442 Year: 2008 Validation of assays for inflammatory mediators in exhaled breath condensate Source: Eur Respir J 2008; 31: 943-948 Year: 2008 Changes in sputum concentrations of leukotrienes and thromboxane after dry air hyperventilation in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 412s Year: 2003